Search results
Factor XIIa, Human
Research studies or protocols where a source of highly purified human factor XIIa is required.
CRYOcheck Factor IX Deficient Plasma, frozen
Deficient substrate for clot-based factor IX assays.
CRYOcheck Factor IX Deficient Plasma, frozen
Deficient substrate for clot-based factor IX assays.
Thrombin (IIa), anti-human mouse, IgG
Factor II (Prothrombin), anti-human, mouse, IgG
ZYMUTEST Protein S Total
Diagnosis of protein S deficiencies (congenital, acquired or transitory) • Type I deficiency: Partial deficiency of total and free protein S antigen • Type II deficiency: Normal total and free protein S antigen, reduced activity • Type III deficiency: Normal total antigen, decreased activity and free antigen, assay of protein S in clinical studies.
Protein Z, Human
ZYMUTEST HIA, IgGAM Screening
Assessment of the risk to develop HIT/HITT, in patients treated with heparins (unfractionated or LMWH): presence of antibodies is a risk indicator for development of HIT/HITT. Clinical suspicion of HIT during heparin therapy.
ZYMUTEST vWF:CBA (Collagen Binding Assay)
Diagnosis of von Willebrand disease (vWD). Assay of vWF:CBA in clinical samples, as a disease marker or as an indicator for cardiovascular diseases.
ZYMUTEST HIA Mono-Strip, IgG
Individual test. Clinical suspicion of HIT during heparin therapy. Heparin-dependent antibodies of the IgG isotype are those strongly associated with the clinical diagnosis of HIT. The ZYMUTEST HIA Mono Strip IgG assay offers then a better specificity for the clinical complication of HIT, but it has less sensitivity as cases associated with only IgM and/or IgA isotypes are missed.